128 related articles for article (PubMed ID: 27039814)
1. Recombinant Human Bone Morphogenetic Protein-2 in Development and Progression of Oral Squamous Cell Carcinoma.
Zaid KW; Chantiri M; Bassit G
Asian Pac J Cancer Prev; 2016; 17(3):927-32. PubMed ID: 27039814
[TBL] [Abstract][Full Text] [Related]
2. BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.
Kim MJ; Kim KM; Kim J; Kim KN
PLoS One; 2014; 9(10):e108170. PubMed ID: 25271422
[TBL] [Abstract][Full Text] [Related]
3. BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.
Sand JP; Kokorina NA; Zakharkin SO; Lewis JS; Nussenbaum B
Otolaryngol Head Neck Surg; 2014 Feb; 150(2):245-50. PubMed ID: 24247005
[TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
6. RhBMP-2 Activates Hippo Signaling through RASSF1 in Esophageal Cancer Cells.
Kim SM; Ye S; Rah SY; Park BH; Wang H; Kim JR; Kim SH; Jang KY; Lee KB
Sci Rep; 2016 May; 6():26821. PubMed ID: 27230238
[TBL] [Abstract][Full Text] [Related]
7. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Carreira AC; Zambuzzi WF; Rossi MC; Astorino Filho R; Sogayar MC; Granjeiro JM
Vitam Horm; 2015; 99():293-322. PubMed ID: 26279381
[TBL] [Abstract][Full Text] [Related]
9. rhBMP-2 has adverse effects on human oral carcinoma cell lines in vivo.
Kokorina NA; Lewis JS; Zakharkin SO; Krebsbach PH; Nussenbaum B
Laryngoscope; 2012 Jan; 122(1):95-102. PubMed ID: 21997819
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of miR-455-5p by the TGF-β-SMAD signalling axis promotes the proliferation of oral squamous cancer cells by targeting UBE2B.
Cheng CM; Shiah SG; Huang CC; Hsiao JR; Chang JY
J Pathol; 2016 Sep; 240(1):38-49. PubMed ID: 27235675
[TBL] [Abstract][Full Text] [Related]
11. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma.
Gao Q; Tong W; Luria JS; Wang Z; Nussenbaum B; Krebsbach PH
Int J Oral Maxillofac Surg; 2010 Mar; 39(3):266-71. PubMed ID: 20074910
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-2/4 and bone morphogenetic protein receptor type IA expression in metastatic and nonmetastatic oral squamous cell carcinoma.
Soares AF; Xavier RL; da Costa Miguel MC; de Souza LB; Pinto LP
Am J Otolaryngol; 2010; 31(4):266-71. PubMed ID: 20015767
[TBL] [Abstract][Full Text] [Related]
13. Lack of Effects of Recombinant Human Bone Morphogenetic Protein2 on Angiogenesis in Oral Squamous Cell Carcinoma Induced in the Syrian hamster Cheek Pouch.
Zaid KW; Nhar BM; Ghadeer Alanazi SM; Murad R; Domani A; Alhafi AJ
Asian Pac J Cancer Prev; 2016; 17(7):3527-31. PubMed ID: 27510004
[TBL] [Abstract][Full Text] [Related]
14. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
[TBL] [Abstract][Full Text] [Related]
15. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
Wang SJ; Earle C; Wong G; Bourguignon LY
Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
[TBL] [Abstract][Full Text] [Related]
16. Roles of FGFR in oral carcinogenesis.
Xie X; Wang Z; Chen F; Yuan Y; Wang J; Liu R; Chen Q
Cell Prolif; 2016 Jun; 49(3):261-9. PubMed ID: 27218663
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human bone morphogenetic protein 7 (rhBMP-7) on the behaviour of oral squamous cell carcinoma: a preliminary in vitro study.
Lappin DF; Abu-Serriah M; Hunter KD
Br J Oral Maxillofac Surg; 2015 Feb; 53(2):158-63. PubMed ID: 25480012
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review).
Ye L; Bokobza SM; Jiang WG
Int J Mol Med; 2009 Nov; 24(5):591-7. PubMed ID: 19787192
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal: LncRNA NEAT2 regulates oral squamous cell carcinoma progression via VEGFB and TGF-β/Smad3 pathway.
Oral Dis; 2024 Apr; 30(3):1733. PubMed ID: 36691734
[No Abstract] [Full Text] [Related]
20. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
